Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinomaGRANKVIST, K; LJUNGBERG, B; RASMUSON, T et al.International journal of cancer. 1997, Vol 74, Num 2, pp 233-236, issn 0020-7136Article

Retrorectal cystic hamartoma as benign cause of CA 19-9 elevationGARCIA-DONAS, Jesus; RODRIGUEZ, Nuria; JARA, Carlos et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 4012-4014, issn 0732-183X, 3 p.Article

Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinomaNEGISHI, Y; FURUKAWA, T; OKA, T et al.Gynecologic and obstetric investigation. 1987, Vol 23, Num 3, pp 200-207, issn 0378-7346Article

The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEATAYYAR, M; TUTUS, A.International journal of fertility and women's medicine. 1999, Vol 44, Num 5, pp 256-259, issn 1534-892XArticle

Tumor markers in the diagnosis of malignant serous effusionsCASCINU, S; DEL FERRO, E; BARBANTI, I et al.American journal of clinical oncology. 1997, Vol 20, Num 3, pp 247-250, issn 0277-3732Article

Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant womenKOBAYASHI, F; SAGAWA, N; NAKAMURA, K et al.American journal of obstetrics and gynecology. 1989, Vol 160, Num 3, pp 563-566, issn 0002-9378Article

Diagnostic, prognostic and monitoring value of CA 72.4 in gastric cancer. A prospective study including CA 19.9 and CEACAZIN, J. L; GAMBIER, L; GOSSELIN, P et al.Immuno analyse & biologie spécialisée. 1998, Vol 13, Num 3, pp 141-150, issn 0923-2532Article

Relevance of SCC-Ag, cea, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancerKRIMMEL, M; HOFFMANN, J; KRIMMEL, C et al.Journal of cranio-maxillo-facial surgery. 1998, Vol 26, Num 4, pp 243-248, issn 1010-5182Article

Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lungBERTHIOT, G; MARECHAL, F; CATTAN, A et al.Biomedicine & pharmacotherapy. 1989, Vol 43, Num 8, pp 613-620, issn 0753-3322Article

Évaluation analytique et clinique des marqueurs tumoraux Vitros ECi = Tumor marker multicenter analytical and clinical evaluation with Vitros EciECHE, N; RIEDINGER, J.-M; BASUYAU, J.-P et al.Immuno analyse & biologie spécialisée. 2001, Vol 16, Num 5, pp 324-337, issn 0923-2532Article

Menstrual cycle dependent variability for serum tumor markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in healthy womenERBAGCI, A. B; YILMAZ, N; KUTLAR, I et al.Disease markers. 1999, Vol 15, Num 4, pp 259-267, issn 0278-0240Article

Maternal serum and umbilical cord tumor marker levels at term pregnancyKIRAN, Gurkan; KIRAN, Hakan; GULER, Fatma Inanc et al.Acta obstetricia et gynecologica Scandinavica. 2005, Vol 84, Num 1, pp 85-89, issn 0001-6349, 5 p.Article

Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?AYHAN, Ali; GUVEN, Suleyman; GUVEN, Emine Seda Guvendag et al.Acta obstetricia et gynecologica Scandinavica. 2007, Vol 86, Num 4, pp 484-490, issn 0001-6349, 7 p.Article

Dosage des marqueurs tumoraux ACE, CA 15.3, CA 125 et CA 19.9 dans les liquides d'épanchement et le LCR par immunoanalyse en phase homogène. Corrélation avec les résultats cytologiques et les concentrations sériques = Assay of tumor markers (CEA, CA 15-3, CA 125 and CA 19-9) in malignant effusions and cerebrospinal fluid by aid of Kryptor: correlation with cytologic results and blood concentrationsGUEPRATTE, S; PALLUD, C; PICHON, M. F et al.Immuno analyse & biologie spécialisée. 2002, Vol 17, Num 1, pp 18-25, issn 0923-2532Article

Pièges et problèmes analytiques dans le dosage des marqueurs tumoraux circulants = Pitfalls and analytical problems in the measuring of tumour markersBUGUGNANI, M. J; NERBONNE-BLETON, F.Spectra biologie. 2000, Vol 19, Num 112, pp 31-35, issn 0295-1967Conference Paper

Marqueurs tumoraux en cancérologie gynécologique = Tumorous markers in gynecological neoplasmsMIGNOT, L.Contraception, fertilité, sexualité (1991). 1999, Vol 27, Num 10, pp 670-674, issn 1157-8181Article

Elevated carbohydrate antigen 19-9 in a dermoid cystATABEKOGLU, C; BOZACI, E. A; TEZCAN, S et al.International journal of gynaecology and obstetrics. 2005, Vol 91, Num 3, pp 262-263, issn 0020-7292, 2 p.Article

The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovaryALTARAS, M. M; GOLDBERG, G. L; LEVIN, W et al.Gynecologic oncology (Print). 1986, Vol 25, Num 2, pp 150-159, issn 0090-8258Article

Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosisHARADA, Tatsuya; KUBOTA, Toshiro; ASO, Takeshi et al.Fertility and sterility. 2002, Vol 78, Num 4, pp 733-739, issn 0015-0282, 7 p.Article

Tumor markers in non-malignant diseasesTOUITOU, Y; BOGDAN, A.European journal of cancer & clinical oncology. 1988, Vol 24, Num 7, pp 1083-1091, issn 0277-5379Article

The value of CA 125 serum assay in the management of ovarian cancerLAMBERT, J.British journal of obstetrics and gynaecology (Print). 1987, Vol 94, Num 3, pp 193-195, issn 0306-5456Article

Increased serum CA 125 levels during the first trimester of pregnancySEKI, K; KIKUCHI, Y; UESATO, T et al.Acta obstetricia et gynecologica Scandinavica. 1986, Vol 65, Num 6, pp 583-585, issn 0001-6349Article

Predictive Value of Serum Carbohydrate Antigen 19-9 in Malignant Intraductal Papillary Mucinous NeoplasmsBIN XU; ZHENG, Wen-Van; JIN, Da-Yong et al.World journal of surgery. 2011, Vol 35, Num 5, pp 1103-1109, issn 0364-2313, 7 p.Article

Amélioration de la prescription de marqueurs tumoraux sériques dans un hôpital général = Assessment of a program designed to improve orders for serum tumor markers in a general hospitalPARIENTE, A; PREVOST, J; MONTAUT, N et al.La Presse médicale (1983). 1998, Vol 27, Num 4, pp 153-156, issn 0755-4982Article

Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancerALOE, S; D'ALESSANDRO, R; COSIMELLI, M et al.The International journal of biological markers. 2003, Vol 18, Num 1, pp 21-27, issn 0393-6155, 7 p.Article